A

Active Director Director DIN 01836608
DIN 01836608 First appointment Jan 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2005
Shareholding value •••• Premium profile

About Astha

Data last updated:

Astha is a Director at Vartika Chemicals & Pharmaceuticals Private Limited (since 2005). The company operates in Pharma. Vartika Chemicals & Pharmaceuticals Private Limited reported revenue of ₹120 Cr (FY 2025).

DIN 01836608
Primary Designation Director
Industry Pharma
First Appointment 30 Jan 2005
Oldest Company Age 22 yrs
Largest company Vartika Chemicals & Pharmaceuticals Private Limited · ₹120 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Jan 20052004₹120 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Vartika Chemicals & Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Astha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Astha

Astha currently holds 1 directorship: Vartika Chemicals & Pharmaceuticals Private Limited (Director, since 30 Jan 2005, revenue ₹120 Cr (FY 2025)).

Astha was first appointed on 30 Jan 2005 as Director at Vartika Chemicals & Pharmaceuticals Private Limited.

The current boards of Astha's companies include Kamal Nayan Tripathi (Vartika Chemicals & Pharmaceuticals Private Limited), Vartika Tripathi (Vartika Chemicals & Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available